What Claims Databases Can Tell Us about Real-World Data and Treatment Approaches in Metastatic Breast Cancer

Researchers use real-world data to study treatment patterns, drug sequencing, and biomarker associations.

Your gift is doubled through December 31.

Donate Now
Date
August 13, 2026

Seth Wander, MD, PhD, Mass General, and Maxwell Lloyd, MD, Beth Israel Deaconess Medical Center, discuss the growing use of real-world data to study treatment patterns, drug sequencing, and biomarker associations in metastatic breast cancer.

Drawing on recent claims database analyses and observational research, this session examines how these data are used to evaluate clinical practice, generate hypotheses, and identify evidence gaps—while also exploring the important limitations and challenges of interpreting real-world evidence.

Speakers

Seth Wander, MD, PhD
Mass General
Maxwell Lloyd, MD
Beth Israel Deaconess Medical Center